Univest
Univest
  • Markets

Granules India (GRANULES) Share Price Falls 2.04% Today: What the Move Shows

  • September 2, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Granules India Share Price
Granules India (GRANULES) share price fell to Rs 799.8 today, down 2.04% from the previous close. Market cap was Rs 21,812.84 crore.

Granules India Share Price fell to Rs 799.8 in early trade on 18 November 2026, down 2.04% from the previous close of Rs 816.45. The company’s market capitalisation stood at Rs 21,812.84 crore, which places it in the Large Cap category. The move keeps Granules India Share Price in focus for investors tracking pharmaceutical counters, especially because the stock opened at Rs 819 and then slipped to the day’s low of Rs 799.8. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. Granules India Share Price Today therefore reflects price action first, while the fundamental backdrop, sector benchmark and peer valuation provide the broader context for Granules India Share Price News and Granules India Stock News.

Table of Contents

Toggle
  • Granules India (GRANULES) Share Price Today: Price Action Analysis
  • Granules India (GRANULES) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Granules India
  • About Granules India
  • Track Granules India Share Price on Univest
  • Frequently Asked Questions
    • Why did Granules India Share Price fall today?
    • What is Granules India Share Price today?
    • How much did Granules India Share Price change today?
    • What is Granules India’s market capitalisation?
    • What does Granules India Share Price valuation show?
    • How do ROE and ROCE look for Granules India Share Price?
    • How does Granules India Share Price compare with peers?
    • What are the key numbers behind Granules India Share Price?
    • Where can investors track Granules India Share Price news?

Granules India (GRANULES) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 799.8
Previous Close Rs 816.45
Today's Move -Rs 16.65 (-2.04%)
Open Rs 819
High Rs 819
Low Rs 799.8
Market Capitalisation Rs 21,812.84 crore
Market Cap Category Large Cap

Granules India Share Price Today shows a decline of Rs 16.65, or 2.04%, from the previous close. The stock opened at Rs 819, matched the day’s high at Rs 819, and touched a low of Rs 799.8, which was also the last traded level at the time of this update. Granules India Share Price therefore moved in a narrow range after the open, before settling at the lower end of the band. The Large Cap label and Rs 21,812.84 crore market capitalisation place Granules India among the larger listed names in healthcare. For Granules India Share Price Today watchers, the key point is the gap between the opening level and the current trade, which keeps Granules India Share Price Fall in the spotlight and leads naturally into Granules India Fundamental Analysis.

Granules India (GRANULES) Fundamental Analysis

Metric Value
Market Capitalisation Rs 21,812.84 crore
P/E Ratio 31.21x
P/B Ratio 3.39x
ROE 14.13%
ROCE 15.74%
EPS Rs 26.16
Book Value Per Share Rs 240.73
Dividend Yield 0.21%

Granules India (GRANULES) fundamental metrics show P/E 31.21x, P/B 3.39x, ROE 14.13%, ROCE 15.74%. These figures provide context only and are not a buy or sell signal.

Granules India has a market capitalisation of Rs 21,812.84 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.21x, P/B at 3.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.16, book value per share of Rs 240.73, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 31.21x
Benchmark Median P/E 31.01x
Benchmark Average P/E 58.7x
Benchmark P/E Range 2.75x to 1,425.63x
Company P/B Ratio 3.39x
Benchmark Median P/B 2.88x
Benchmark Average P/B 3.29x
Company ROE 14.13%
Benchmark Median ROE 11.33%
Benchmark Average ROE 4.71%
Company ROCE 15.74%
Benchmark Median ROCE 13.1%
Benchmark Average ROCE 12.06%
Company Market Capitalisation Rs 21,812.84 crore
Benchmark Median Market Cap Rs 791.38 crore
Benchmark Average Market Cap Rs 14,698.18 crore

Granules India (GRANULES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Granules India (GRANULES) has a P/E ratio of 31.21x, which is above the benchmark median of 31.01x, a difference of +0.64%. On its own, the P/E gap is a valuation reference point, not a trading call.

Granules India (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.33%, a difference of +24.71%. Granules India (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.1%, a difference of +20.15%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,47,943.84 40.92 5.03 14.85 19.11
Divi's Laboratories DIVISLAB 2,94,962.14 87.74 16.4 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,78,390.62 83.65 9.67 26.76 19.27
Laurus Labs LAURUSLABS 1,19,789.92 94.36 20.86 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,18,603.21 28.7 4.31 19.69 21.39

Granules India (GRANULES) has a P/E ratio of 31.21x compared with the displayed peer median of 83.65x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 14.13% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India (GRANULES) has a market capitalisation of Rs 21,812.84 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Granules India

  • Granules India Share Price is down 2.04% today, keeping the name active in Granules India Stock News and Granules India Share Price Today tracking.
  • Granules India Share Price opened at Rs 819 and last traded at Rs 799.8, showing the day’s visible price action.
  • Granules India Share Price carries a P/E of 31.21 and P/B of 3.39, which places valuation near the industry median.
  • Granules India Share Price has ROE of 14.13% and ROCE of 15.74%, both above the industry medians in the same sector benchmark.
  • Granules India Share Price sits in the Large Cap category, with a market capitalisation of Rs 21,812.84 crore.

About Granules India

Granules India operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of the listed pharmaceutical universe that is often assessed through Granules India Share Price, company financials and sector comparison rather than through broad market commentary. Its business context fits the wider drug manufacturing and healthcare supply chain, which makes Granules India Share Price relevant to investors who follow formulation and pharmaceutical names. In this update, the verified focus remains on Granules India Share Price, Granules India Stock News and the company’s placement within its industry and sector, rather than on any unsupported operational claim.

Track Granules India Share Price on Univest

Use Granules India (GRANULES) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Granules India Share Price on Univest for live updates, fundamental ratios, market cap context, 52-week levels and market insights. Granules India Share Price Today pages help investors compare price action with valuation, ROE, ROCE, EPS and book value in one place. Univest also brings Granules India Stock Analysis and Granules India Share Price News together for a cleaner view of the stock’s movement.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why did Granules India Share Price fall today?

Ans. Granules India Share Price fell 2.04% to Rs 799.8 from Rs 816.45. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The stock opened at Rs 819.

What is Granules India Share Price today?

Ans. Granules India Share Price was Rs 799.8 at the latest update on 18 November 2026 at 10:53:06 AM IST. It was below the previous close of Rs 816.45 and traded near the day’s low.

How much did Granules India Share Price change today?

Ans. Granules India Share Price declined by Rs 16.65, which equals 2.04%. The move took the stock from the previous close of Rs 816.45 to Rs 799.8 during the morning session.

What is Granules India’s market capitalisation?

Ans. Granules India has a market capitalisation of Rs 21,812.84 crore. That places Granules India Share Price in the Large Cap category, which is useful context when comparing the stock with other healthcare names.

What does Granules India Share Price valuation show?

Ans. Granules India Share Price carries a P/E of 31.21 and a P/B of 3.39. The P/E is close to the industry median of 31.01, while the P/B is slightly above the benchmark median of 2.88.

How do ROE and ROCE look for Granules India Share Price?

Ans. Granules India Share Price is backed by ROE of 14.13% and ROCE of 15.74%. Both are above the industry medians in the same benchmark set, which gives the stock a measurable returns profile.

How does Granules India Share Price compare with peers?

Ans. Granules India Share Price sits below expensive peers like Laurus Labs and Divi’s Laboratories on P/E, but above Zydus Lifesciences and Aurobindo Pharma. Its valuation is closer to the industry middle than the extremes.

What are the key numbers behind Granules India Share Price?

Ans. The key numbers are Rs 799.8 current price, Rs 816.45 previous close, P/E of 31.21, P/B of 3.39, EPS of Rs 26.16 and book value of Rs 240.73. These figures frame Granules India Share Price.

Where can investors track Granules India Share Price news?

Ans. Investors can track Granules India Share Price on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels and stock news. That makes Granules India Share Price Today easier to monitor in one view.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply